Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers.

Thadani NN, Yang J, Moyo B, Lee CM, Chen MY, Bao G, Suh J.

ACS Synth Biol. 2020 Feb 18. doi: 10.1021/acssynbio.9b00341. [Epub ahead of print]


Deauville Dubiosity.

Yang JC, Yahalom J.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):16. doi: 10.1016/j.ijrobp.2018.09.032. No abstract available.


NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.

Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, Schachter NF, McCuaig JM, Kim RH.

Cancers (Basel). 2019 May 22;11(5). pii: E707. doi: 10.3390/cancers11050707.


Multidisciplinary Care is the Best Approach, Anytime.

Yang JC.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):296. doi: 10.1016/j.ijrobp.2018.09.045. No abstract available.


Brachytherapy Training Survey of Radiation Oncology Residents.

Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560. doi: 10.1016/j.ijrobp.2018.10.023. Epub 2018 Oct 26.


Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.

Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, Efstathiou JA.

Clin Genitourin Cancer. 2019 Feb;17(1):23-31.e3. doi: 10.1016/j.clgc.2018.09.023. Epub 2018 Oct 4.


Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.

An Y, Adams JR, Hollern DP, Zhao A, Chang SG, Gams MS, Chung PED, He X, Jangra R, Shah JS, Yang J, Beck LA, Raghuram N, Kozma KJ, Loch AJ, Wang W, Fan C, Done SJ, Zacksenhaus E, Guidos CJ, Perou CM, Egan SE.

Cell Rep. 2018 Oct 16;25(3):702-714.e6. doi: 10.1016/j.celrep.2018.09.056.


Early-Stage Follicular Lymphoma: What Is the Preferred Treatment Strategy?

Yang JC, Yahalom J.

J Clin Oncol. 2018 Oct 10;36(29):2904-2906. doi: 10.1200/JCO.2018.79.3075. Epub 2018 Aug 28. No abstract available.


Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.

Vardhana S, Hamlin PA, Yang J, Zelenetz A, Sauter CS, Matasar MJ, Ni A, Yahalom J, Moskowitz CH.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2133-2138. doi: 10.1016/j.bbmt.2018.06.009. Epub 2018 Jun 15.


Adolescent mental health education InSciEd Out: a case study of an alternative middle school population.

Yang J, Lopez Cervera R, Tye SJ, Ekker SC, Pierret C.

J Transl Med. 2018 Apr 3;16(1):84. doi: 10.1186/s12967-018-1459-x.


Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report.

Krebs S, Ganly I, Ghossein R, Yang J, Yahalom J, Schöder H.

Front Oncol. 2017 Nov 27;7:284. doi: 10.3389/fonc.2017.00284. eCollection 2017.


Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH.

Blood. 2016 Sep 15;128(11):1458-64. doi: 10.1182/blood-2016-03-703470. Epub 2016 Jul 25.


Students being and becoming scientists: measured success in a novel science education partnership.

Yang J, LaBounty TJ, Ekker SC, Pierret C.

Palgrave Commun. 2016;2. pii: 16005. doi: 10.1057/palcomms.2016.5. Epub 2016 Mar 1.


Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors.

Yang JC, Terezakis SA, Dunkel IJ, Gilheeney SW, Wolden SL.

Pediatr Blood Cancer. 2016 Apr;63(4):646-51. doi: 10.1002/pbc.25867. Epub 2015 Dec 24.


Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).

Jurutka PW, Kaneko I, Yang J, Bhogal JS, Swierski JC, Tabacaru CR, Montano LA, Huynh CC, Jama RA, Mahelona RD, Sarnowski JT, Marcus LM, Quezada A, Lemming B, Tedesco MA, Fischer AJ, Mohamed SA, Ziller JW, Ma N, Gray GM, van der Vaart A, Marshall PA, Wagner CE.

J Med Chem. 2013 Nov 14;56(21):8432-54. doi: 10.1021/jm4008517. Epub 2013 Nov 1.


Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.

Yang JC, Wexler LH, Meyers PA, Happersett L, La Quaglia MP, Wolden SL.

Pediatr Blood Cancer. 2013 Oct;60(10):1616-20. doi: 10.1002/pbc.24502. Epub 2013 Jun 13.


Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report.

Yang JC, Chou AJ, Oeffinger KC, La Quaglia MP, Wolden SL.

J Pediatr Surg. 2012 Oct;47(10):1943-5. doi: 10.1016/j.jpedsurg.2012.08.014.


Parameningeal rhabdomyosarcoma: outcomes and opportunities.

Yang JC, Wexler LH, Meyers PA, Wolden SL.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e61-6. doi: 10.1016/j.ijrobp.2012.08.019. Epub 2012 Sep 25.


Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).

Furmick JK, Kaneko I, Walsh AN, Yang J, Bhogal JS, Gray GM, Baso JC, Browder DO, Prentice JL, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Kwon JS, Quezada A, Reyes NM, Lemming B, Saini P, van der Vaart A, Groy TL, Marshall PA, Jurutka PW, Wagner CE.

ChemMedChem. 2012 Sep;7(9):1551-66.


Phantosmia during radiation therapy: a report of 2 cases.

Yang JC, Khakoo Y, Lightner DD, Wolden SL.

J Child Neurol. 2013 Jun;28(6):791-4. doi: 10.1177/0883073812450616. Epub 2012 Jul 17.


Supplemental Content

Loading ...
Support Center